blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3448433

EP3448433 - COVALENT BTK INHIBITORS AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.07.2021
Database last updated on 05.08.2024
FormerGrant of patent is intended
Status updated on  28.10.2020
FormerRequest for examination was made
Status updated on  01.02.2019
FormerThe international publication has been made
Status updated on  04.11.2017
Most recent event   Tooltip16.07.2021Application deemed to be withdrawnpublished on 18.08.2021  [2021/33]
Applicant(s)For all designated states
X-Chem, Inc.
100 Beaver Street, Suite 101
Waltham, Massachusetts 02453 / US
[2019/10]
Inventor(s)01 / CLARK, Matthew
36 Clelland Road
Lexington MA 02421 / US
02 / KEEFE, Anthony, D.
9 Bellis Circle 6
Cambridge MA 02140 / US
03 / GUILINGER, John
40 Crescent Street
Wakefield MA 01880 / US
04 / ZHANG, Ying
84 Winter Street
Lexington MA 02420 / US
05 / TIAN, Xia
931 Massachusetts Ave
604
Cambridge MA 02139 / US
 [2019/10]
Representative(s)Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2019/10]Bösl, Raphael Konrad
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
Application number, filing date17790572.628.04.2017
[2019/10]
WO2017US30185
Priority number, dateUS201662329708P29.04.2016         Original published format: US 201662329708 P
[2019/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017190048
Date:02.11.2017
Language:EN
[2017/44]
Type: A1 Application with search report 
No.:EP3448433
Date:06.03.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 02.11.2017 takes the place of the publication of the European patent application.
[2019/10]
Search report(s)International search report - published on:US02.11.2017
(Supplementary) European search report - dispatched on:EP18.10.2019
ClassificationIPC:C07D207/277, C07D209/42, C07D277/06, C07D303/48, C07D471/04, A61P7/00, A61P7/06, A61P17/06, A61P25/00, A61P35/00, A61K47/10, A61K31/505
[2020/45]
CPC:
C07D303/48 (EP,US); C07D471/04 (EP,US); A61P17/06 (EP);
A61P25/00 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/00 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61P7/06 (EP); C07D207/16 (US);
C07D207/277 (EP); C07D209/42 (EP,US); C07D277/06 (EP);
C07D277/56 (US) (-)
Former IPC [2019/10]A61K47/10, A61K31/505
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/10]
Extension statesBA17.12.2018
ME17.12.2018
Validation statesMA17.12.2018
MD17.12.2018
TitleGerman:KOVALENTE BTK-INHIBITOREN UND VERWENDUNGEN DAVON[2019/10]
English:COVALENT BTK INHIBITORS AND USES THEREOF[2019/10]
French:INHIBITEURS COVALENTS DE BTK ET LEURS UTILISATIONS[2019/10]
Entry into regional phase22.11.2018National basic fee paid 
22.11.2018Search fee paid 
22.11.2018Designation fee(s) paid 
22.11.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
22.11.2018Examination requested  [2019/10]
07.05.2020Amendment by applicant (claims and/or description)
29.10.2020Communication of intention to grant the patent
10.03.2021Application deemed to be withdrawn, date of legal effect  [2021/33]
01.04.2021Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2021/33]
Fees paidRenewal fee
29.04.2019Renewal fee patent year 03
27.04.2020Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.202105   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - XING LI ET AL, "Bruton's TK inhibitors: structural insights and evolution of clinical candidates", FUTURE MEDICINAL CHEMISTRY, LONDON : FUTURE SCIENCE, UK, vol. 6, no. 6, ISSN 1756-8927, (20140331), pages 675 - 695, (20140604), XP009506630 [A] 1-16 * figure 10; examples 11,13 *
International search[A]US2005215603  (AKRITOPOULOU-ZANZE IRINI [US], et al) [A] 1, 2, 4, 12, 14, 20-23, 30 * , entire document, especially: para [0381], (5S)-1-(1,3,4,9-Tetrahydro-?-carbolin-2-yl)-2-[5-(thiazolidine3-carbonyl )-pyrrolid in-3-yl]-ethanone. *;
 [A]  - ZHENG et al., "Synthesis and Biological Evaluation of Novel Tetrahydro-?-carboline Derivatives - as Antitumor Growth and Metastasis Agents through Inhibiting the Transforming Growth Factor- beta Signaling Pathway", J. Med. Chem., (20140213), vol. 57, no. 3, doi:10.1021/jm401117t, ISSN 0022-2623, pages 600 - 612, XP055551495 [A] 1, 2, 4, 12, 14, 20-23, 30 * , entire document, especially: pg 602, Table 1, compound 8a. *

DOI:   http://dx.doi.org/10.1021/jm401117t
 [A]  - ORTAR et al., "Tetrahydro-beta-carboline derivatives targeting fatty acid amide hydrolase - (FAAH) and transient receptor potential (TRP) channels", Bioorganic & Medicinal Chemistry Letters, (20130000), vol. 23, pages 138 - 142, XP028961588 [A] 1, 2, 4, 12, 14, 20-23, 30 * , entire document, especially: pg 140, Table 1, compound 4f. *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2012.10.137
 [A]  - PubChem, (20151218), Database accession no. 101236951, XP055436891 [A] 1, 2, 4, 12, 14, 20-23, 30
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.